ALI/ARDS induces the release of proinflammatory cytokines and chemokines by activating the NF-κB signaling pathway, whereas FXR inhibits the NF-κB signaling pathway and also hinders MAPK and PI3K/Akt signaling pathways. The gene discussed is AKT1; the disease is acute respiratory distress syndrome.